New obesity pill enters human testing
NCT ID NCT07310901
Summary
This is an early-stage study to test a new daily pill called CRB-913 for weight loss in people with obesity. The main goals are to see if the drug is safe, how the body processes it, and if it helps reduce body weight. About 252 participants will take either the drug or a placebo (a dummy pill) for 12 weeks, followed by a month of monitoring.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESE BUT OTHERWISE HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Accel Research Sites
RECRUITINGDeLand, Florida, 32720, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Alliance Clinical
RECRUITINGLas Vegas, Nevada, 89109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Arizona Clinical Trials
RECRUITINGChandler, Arizona, 85225, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Central Alabama Research
RECRUITINGBirmingham, Alabama, 35209, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Flourish Research
RECRUITINGSan Antonio, Texas, 78229, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Louisville Metabolic and Atherosclerosis Research Center
RECRUITINGLouisville, Kentucky, 40213, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Lucas Research
RECRUITINGMorehead City, North Carolina, 28557, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Medpace Clinical Pharmacology
RECRUITINGCincinnati, Ohio, 45227, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Neurobehavioral Research
RECRUITINGCedarhurst, New York, 11516, United States
Contact
Contact Phone: •••-•••-••••
-
Prospective Research Innovations
RECRUITINGRancho Cucamonga, California, 91730, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Quotient Sciences
RECRUITINGMiami, Florida, 33126, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Rochester Clinical Research
RECRUITINGRochester, New York, 14609, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Tampa Bay Medical Research
RECRUITINGLargo, Florida, 33761, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Velocity Clinical Research
RECRUITINGCleveland, Ohio, 44122, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Velocity Clinical Research
RECRUITINGDallas, Texas, 75230, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.